194 related articles for article (PubMed ID: 5678271)
1. [Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin].
Haustein UF
Arch Klin Exp Dermatol; 1968; 232(3):245-59. PubMed ID: 5678271
[No Abstract] [Full Text] [Related]
2. [The localization of the tissue activator of fibrinolysis in dermatoses].
Haustein UF
Arch Klin Exp Dermatol; 1969; 234(2):182-94. PubMed ID: 4241665
[No Abstract] [Full Text] [Related]
3. Scaly lesions.
Tidman MJ
Practitioner; 1991 Apr; 235(1501):340-6. PubMed ID: 1857671
[No Abstract] [Full Text] [Related]
4. Cell proliferation kinetics in benign and malignant skin diseases in humans.
Weinstein GD; Frost P
Natl Cancer Inst Monogr; 1969 May; 30():225-46. PubMed ID: 5361648
[No Abstract] [Full Text] [Related]
5. [On the usability of the so-called phospholipid-demonstration methods in dermatohistology. II. Nonstaining methods].
Cramer HJ
Arch Klin Exp Dermatol; 1967; 229(4):422-8. PubMed ID: 4297560
[No Abstract] [Full Text] [Related]
6. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
Giordano G
Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
[No Abstract] [Full Text] [Related]
7. Tumours of the skin.
Zackheim HS
IARC Sci Publ (1971); 1973; (5):1-21. PubMed ID: 4377994
[No Abstract] [Full Text] [Related]
8. Multiple clear-cell acanthoma and ichthyosis.
Landry M; Winkelmann RK
Arch Dermatol; 1972 Mar; 105(3):371-83. PubMed ID: 4334961
[No Abstract] [Full Text] [Related]
9. [Unusual histologic image of some systematized verrucous naevi].
Degos R; Civatte J; Belaïch S; Tsoïtis G
Ann Dermatol Syphiligr (Paris); 1969; 96(4):361-74. PubMed ID: 4243905
[No Abstract] [Full Text] [Related]
10. Fibrinolysis.
Harbrecht PJ
South Med J; 1967 Feb; 60(2):209-14. PubMed ID: 5334407
[No Abstract] [Full Text] [Related]
11. Skin care. Moisturising solution.
Thompson J
Nurs Times; 1994 Feb 23-Mar 1; 90(8):52-4. PubMed ID: 8127781
[No Abstract] [Full Text] [Related]
12. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation.
Ruchusatsawat K; Wongpiyabovorn J; Protjaroen P; Chaipipat M; Shuangshoti S; Thorner PS; Mutirangura A
Hum Pathol; 2011 Dec; 42(12):1878-87. PubMed ID: 21663940
[TBL] [Abstract][Full Text] [Related]
13. [Clinical studies on activators and inhibitors of fibrinolysis in various internal diseases].
Smolenski WS; Bokarew IN; Jerschow WI; Mindlina GI
Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):138-41. PubMed ID: 4134263
[No Abstract] [Full Text] [Related]
14. Differentiation of postembryonic skin endothelial cells.
Karasek M
J Invest Dermatol; 2007 Dec; 127(12):2710-2. PubMed ID: 18007691
[TBL] [Abstract][Full Text] [Related]
15. [Multiple skin cancer in a patient with psoriasis and lymphogranulomatosis].
Golovchenko DIa; Nedoboĭ PN; Koroleva ZhV
Vestn Dermatol Venerol; 1987; (7):71-2. PubMed ID: 3673253
[No Abstract] [Full Text] [Related]
16. Fibrinolytic activity and the skin.
Kurban AK
Br J Dermatol; 1970 Jan; 82(1):76-7. PubMed ID: 4903784
[No Abstract] [Full Text] [Related]
17. [The occurrence of squamous-cell skin cancer in psoriasis patients].
Anishchenko IS
Vestn Dermatol Venerol; 1990; (11):25-9. PubMed ID: 2288148
[TBL] [Abstract][Full Text] [Related]
18. [Fibrinolytic activity of the skin in psoriasis and various other dermatoses].
Piper HG; Hadlich J; Würbach G
Arch Klin Exp Dermatol; 1967; 228(3):249-58. PubMed ID: 5585159
[No Abstract] [Full Text] [Related]
19. [Fibrinolytic and antifibrinolytic treatment].
Sterkowicz S
Wiad Lek; 1968 Jun; 21(12):1035-41. PubMed ID: 4875370
[No Abstract] [Full Text] [Related]
20. [Practical significance of histochemistry].
Petzoldt D
Arch Klin Exp Dermatol; 1970; 237(1):268-78. PubMed ID: 4984689
[No Abstract] [Full Text] [Related]
[Next] [New Search]
